ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in ADC Therapeutics SA as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −3 vs. Q3 2023
- Shares held
- 34.0M
- −5.49M (−13.9%) vs. Q3 2023
- Total value
- $56.4M
- +$21.0M (+59.3%) vs. Q3 2023
- New holders
- 8
- 7 more added
- Sold out
- 11
- 10 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $86.3M |
| Q1 2026 | 118 | $312.9M |
| Q4 2025 | 115 | $292.8M |
| Q3 2025 | 106 | $271.3M |
| Q2 2025 | 86 | $182.1M |
| Q1 2025 | 82 | $77.3M |
| Q4 2024 | 83 | $112.4M |
| Q3 2024 | 77 | $172.9M |
| Q2 2024 | 74 | $163.7M |
| Q1 2024 | 37 | $155.8M |
| Q4 2023 | 38 | $56.4M |
| Q3 2023 | 41 | $35.4M |
| Q2 2023 | 56 | $97.5M |
| Q1 2023 | 59 | $90.9M |
| Q4 2022 | 60 | $149.1M |
| Q3 2022 | 66 | $176.5M |
| Q2 2022 | 58 | $274.1M |
| Q1 2022 | 49 | $501.3M |
| Q4 2021 | 55 | $682.8M |
| Q3 2021 | 53 | $890.6M |
| Q2 2021 | 56 | $816.3M |
| Q1 2021 | 59 | $801.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 6 | $10 | 0.00% | −1,309−99.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 20 | $33 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 100 | $166 | 0.00% | +100 | New |
| Qube Research & Technologies Ltd | 207 | $344 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 250 | $415 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 300 | $498 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,179 | $1.00K | 0.00% | −53−4.3% | Reduced |
| Group One Trading, L.P. | 2,232 | $3.71K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4,030 | $7.00K | 0.00% | −4,055−50.2% | Reduced |
| Evergreen Capital Management LLC | 11,000 | $18.3K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 14,000 | $23.2K | 0.00% | −8,629−38.1% | Reduced |
| Tower Research Capital LLC (TRC) | 14,641 | $24.3K | 0.00% | +10,521+255.4% | Added |
| Lynx Capital Group Ltd | 15,000 | $24.9K | 0.02% | +15,000 | New |
| Moneta Group Investment Advisors LLC | 19,496 | $32.4K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 19,852 | $33.0K | 0.00% | +19,852 | New |
| Saxony Capital Management, LLC | 20,623 | $34.2K | 0.05% | +20,623 | New |
| Susquehanna International Group, LLP | 20,689 | $34.3K | 0.00% | +20,689 | New |
| Marshall Wace, LLP | 21,848 | $36.3K | 0.00% | −416,825−95.0% | Reduced |
| DLK Investment Management, LLC | 33,155 | $55.0K | 0.03% | +33,155 | New |
| XTX Topco Ltd | 43,650 | $72.5K | 0.02% | −23,401−34.9% | Reduced |
| Magnetar Financial LLC | 55,762 | $92.6K | 0.00% | 00.0% | Unchanged |
| Hennion & Walsh Asset Management, Inc. | 65,936 | $109.5K | 0.01% | +8,069+13.9% | Added |
| HRT Financial LP | 80,086 | $132.0K | 0.00% | +80,086 | New |
| Miracle Mile Advisors, LLC | 84,496 | $140.3K | 0.00% | 00.0% | Unchanged |
| Indie Asset Partners, LLC | 92,700 | $153.9K | 0.14% | 00.0% | Unchanged |
| Jane Street Group, LLC | 101,260 | $168.1K | 0.00% | +101,260 | New |
| Acadian Asset Management LLC | 144,858 | $240.0K | 0.00% | −11,190−7.2% | Reduced |
| GCM Grosvenor Holdings, LLC | 410,888 | $682.1K | 0.12% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 733,568 | $1.22M | 0.29% | 00.0% | Unchanged |
| Morgan Stanley | 781,937 | $1.30M | 0.00% | +117,910+17.8% | Added |
| Vantage Consulting Group Inc | 850,737 | $1.41M | 0.95% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 1,013,540 | $1.68M | 0.34% | −86,460−7.9% | Reduced |
| Goldman Sachs Group Inc | 1,459,514 | $2.42M | 0.00% | +406,536+38.6% | Added |
| Bank of America Corp | 1,525,741 | $2.53M | 0.00% | −8,190−0.5% | Reduced |
| Citadel Advisors LLC | 1,853,412 | $3.08M | 0.00% | −1,044,709−36.0% | Reduced |
| Millennium Management LLC | 2,672,810 | $4.44M | 0.00% | +22,559+0.9% | Added |
| Prosight Management, LP | 6,471,800 | $10.7M | 4.31% | +1,069,759+19.8% | Added |
| Redmile Group, LLC | 15,328,317 | $25.4M | 0.91% | +1,150,272+8.1% | Added |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −3,294,534−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,647,030−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −1,068,468−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −529,890−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −257,162−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −121,897−100.0% | Sold out |
| ELCO Management Co., LLC | 0 | $0 | 0.00% | −21,532−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −19,752−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |